Anti-Asialo GM1 treatment during secondary Toxoplasma gondii infection is lethal and depletes T cells
D. L. Ivanova, S. L. Denton, J. Gigley
This study shows that anti-ASGM1 treatment during secondary Toxoplasma gondii infection causes 100% mortality and depletes T cells, particularly CD8+ effector T cells, highlighting ASGM1 as a marker of activated T cells.
bioRxiv · Feb 18, 2019 · PreprintImmunology